rs1420159591
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001458.5(FLNC):c.1444C>T(p.Arg482*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001458.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461656Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727138
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:1
- -
Hypertrophic cardiomyopathy 26 Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene. Loss of function is the established mechanism of disease for variants in dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy (MIM#617047), myofibrillar myopathy (MIM#609524) and arrhythmogenic right ventricular cardiomyopathy. In distal myopathy (MIM#614065), NMD-predicted variants cause a loss of function, however missense variants have been shown to result in a toxic gain of function (PMID: 32112656). (I) 0107 - This gene is associated with autosomal dominant disease (OMIM). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic, and mostly observed in individuals with dilated cardiomyopathy (DCM) (DECIPHER, PMID: 32112656). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as a VUS, however more recently it has been classified as pathogenic in at least five unrelated individuals with arrhythmogenic cardiomyopathy (ARVC) or DCM (ClinVar - personal communication, PMID: 31627847 (SP) 0902 - This variant has moderate evidence for segregation with disease. This variant has been shown to segregate in two families with DCM or ARVC (PMID: 29235529, PMID: 31627847). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
not provided Pathogenic:1
Identified in patients with DCM and ARVC in published literature (PMID: 31317183, 31627847, 29235529); one family also harbored a MYLK3 variant that segregated with disease; Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31317183, 31627847, 29235529, 34587765) -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg482*) in the FLNC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with dilated cardiomyopathy (PMID: 29235529). ClinVar contains an entry for this variant (Variation ID: 517207). For these reasons, this variant has been classified as Pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg482X v ariant in FLNC has not been previously reported in individuals with cardiomyopat hy but has been identified by our laboratory in 1 individual with DCM and segreg ated with disease in at least 1 affected relative. It was absent from large popu lation studies. This nonsense variant leads to a premature termination codon at position 482, which is predicted to lead to a truncated or absent protein. The F LNC gene is associated with myofibrillar myopathy but variants have recently als o been reported in individuals with isolated inherited cardiomyopathies (includi ng HCM, DCM and RCM). Overall the number of reported variants is still low and l oss of function as a disease mechanism is not yet firmly established for this ge ne. In summary, while there is some suspicion for a pathogenic role, the clinica l significance of the p.Arg482X variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at